Jun 2026 (Q2 FY26) — Aug 11, 2026
Seer, Inc. Q2 FY26 — Scientific Validation Progresses Amidst Commercial Headwinds
Read the full callSeer (SEER) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Seer earnings: last reported Tue, 11 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 3.1 | −23.4% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | -542.9 | −36.1 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | -16.9 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
$2.03 −0.49% · −$0.01
Performance −7.7% 1Y
1Y: $2.2 on 15 Oct 2025 → $2.03. High $2.37 (27 Oct 2025), low $1.62 (2 Jul 2026).
- Previous close
- $2.04
- 52-week range
- $1.62 – $2.37
- One year
- −8.14%
Overview
- Symbol
- SEER
- Sector
- Health Care
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Seer earnings calls (SEER)
Financials
What the filings say
Net profit, year on year: +13% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 |
| Operating profit | -24 | -23 | -21 | -21 | -19 | -17 | -17 | -17 |
| Operating margin | −603.3% | −587.2% | −493.0% | −506.8% | −469.4% | −413.8% | −617.8% | −542.9% |
| Other income | 3 | 2 | 1 | 1 | 1 | 1 | 0 | -0 |
| Profit before tax | -21 | -22 | -20 | -19 | -18 | -16 | -17 | -17 |
| Tax rate | 0.0% | −0.5% | −0.5% | −0.3% | −0.1% | −0.2% | −0.1% | −0.1% |
| Net profit | -21 | -22 | -20 | -19 | -18 | -16 | -17 | -17 |
| EPS ($ per share) | -0.35 | — | — | — | — | — | — | — |
| Line item | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Reserves | -55 | -127 | -219 | -306 | -392 | -466 |
| Total liabilities | 11 | 36 | 41 | 39 | 39 | 37 |
| Fixed assets | 8 | 13 | 19 | 22 | 19 | 15 |
| Total assets | 442 | 539 | 488 | 436 | 367 | 296 |
| Line item | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Cash from operations | -21 | -46 | -61 | -59 | -46 | -44 |
| Cash from investing | -35 | -171 | -123 | 38 | 66 | 62 |
| Cash from financing | 371 | 117 | 4 | 0 | -11 | -11 |
| Net cash flow | 316 | -101 | -180 | -21 | 8 | 7 |
| Capital expenditure | -5 | -7 | -10 | -7 | -4 | -2 |
| Free cash flow | -25 | -53 | -71 | -66 | -50 | -46 |
Insider filings
19 filings between Nov 19, 2025 and Aug 18, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$194.6K
7 sales by 3 insiders
14% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 9
- Award — granted as compensation
Also filed: 3 conversions.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Farokhzad Omid | — | $115.4K | Feb 18, 2026 |
| Horn David R. | — | $56.0K | Aug 18, 2026 |
| Nishar Dipchand | — | $23.3K | Jul 8, 2026 |
Latest filings (34)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Aug 18, 2026 | Horn David R. PRESIDENT & CFO | Sale | 7,309 | $14.8K |
| Jul 28, 2026 | MCGUIRE TERRANCE Director | Award | 16,500 | $0 |
| Jul 28, 2026 | LANGER ROBERT Director | Award | 16,500 | $0 |
| Jul 28, 2026 | Roelofs Nicolas H PHD Director | Award | 16,500 | $0 |
| Jul 28, 2026 | Nishar Dipchand Director | Award | 16,500 | $0 |
| Jul 28, 2026 | Ro Isaac Director | Award | 12,375 | $0 |
| Jul 28, 2026 | Gulyani Meeta Director | Award | 16,500 | $0 |
| Jul 8, 2026 | Nishar Dipchand Director | Sale 10b5-1 plan | 10,660 | $23.3K |
| May 20, 2026 | Horn David R. PRESIDENT & CFO | Sale | 7,303 | $12.4K |
| May 8, 2026 | Bazarko Anthony R. Chief Commercial Officer | Award | 75,000 | — |
| Feb 18, 2026 | Farokhzad Omid CEO AND CHAIR | Sale | 24,385 | $48.6K |
| Feb 18, 2026 | Horn David R. PRESIDENT & CFO | Sale | 7,743 | $15.4K |
| Feb 3, 2026 | Farokhzad Omid CEO AND CHAIR | Award | 697,162 | $0 |
| Feb 3, 2026 | Horn David R. PRESIDENT & CFO | Award | 79,000 | $0 |
| Dec 9, 2025 | MCGUIRE TERRANCE Director | Conversion | 4,088 | — |
| Dec 9, 2025 | Farokhzad Omid CEO AND CHAIR | Conversion | 1,438,057 | — |
| Dec 9, 2025 | Farokhzad Omid CEO AND CHAIR | Conversion | 2,117,138 | — |
| Nov 19, 2025 | Farokhzad Omid CEO AND CHAIR | Sale | 33,838 | $66.7K |
| Nov 19, 2025 | Horn David R. PRESIDENT & CFO | Sale | 6,797 | $13.4K |
| Sep 2, 2025 | Ro Isaac Director | Award | 41,000 | $0 |
| Aug 20, 2025 | Farokhzad Omid CEO AND CHAIR | Sale | 33,992 | $69.5K |
| Aug 20, 2025 | Horn David R. PRESIDENT & CFO | Sale | 6,827 | $14.0K |
| Jul 7, 2025 | Gulyani Meeta Director | Award | 20,500 | $0 |
| Jul 7, 2025 | LANGER ROBERT Director | Award | 20,500 | $0 |
| Jul 7, 2025 | MCGUIRE TERRANCE Director | Award | 20,500 | $0 |
| Jul 7, 2025 | Nishar Dipchand Director | Award | 20,500 | $0 |
| Jul 7, 2025 | Roelofs Nicolas H PHD Director | Award | 17,083 | $0 |
| Jun 13, 2025 | Nishar Dipchand Director | Sale 10b5-1 plan | 30,253 | $62.9K |
| May 20, 2025 | Horn David R. PRESIDENT & CFO | Sale | 6,760 | $14.0K |
| May 20, 2025 | Farokhzad Omid CEO AND CHAIR | Sale | 33,663 | $69.9K |
| Feb 18, 2025 | Farokhzad Omid CEO AND CHAIR | Tax withheld | 88,494 | $203.5K |
| Feb 18, 2025 | Horn David R. PRESIDENT & CFO | Tax withheld | 26,572 | $61.1K |
| Feb 4, 2025 | Farokhzad Omid CEO AND CHAIR | Sale | 8,068 | $18.0K |
| Feb 4, 2025 | Horn David R. PRESIDENT & CFO | Sale | 3,550 | $7.9K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Seer, Inc.
Free account. Everything above stays public.
Write why you follow Seer, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading